Cadrenal Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 05/15/2026 | 45.20 K | $231.43 K | 100.00% | 1.88% | |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 21.63 K | $110.72 K | 48.86% | 0.90% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 8.31 K | $42.55 K | 100.00% | 0.35% |
| JPMORGAN CHASE & CO | 05/13/2026 | 7.50 K | $31.88 K | 0.00% | 0.31% |
| BLACKROCK, INC. | 05/13/2026 | 5.50 K | $28.14 K | 56.05% | 0.23% |
| 05/13/2026 | 1.49 K | $8.00 K | 100.00% | 0.06% | |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 393 | $2.01 K | -26.13% | 0.02% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 300 | $1.54 K | -40.00% | 0.01% |
| DESTINY WEALTH PARTNERS, LLC | 05/11/2026 | 200 | $1.02 K | 100.00% | 0.01% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 05/14/2026 | 150 | $768 | -50.00% | 0.01% |
| MORGAN STANLEY | 05/15/2026 | 100 | $512 | -90.74% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 99 | $507 | 0.00% | 0.00% |
| ARCHER INVESTMENT CORP | 05/04/2026 | 35 | $179 | 0.00% | 0.00% |
| IFP ADVISORS, INC | 04/13/2026 | 30 | $154 | 0.00% | 0.00% |
| UBS GROUP AG | 05/05/2026 | 3 | $15 | -99.71% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 1 | $5 | 100.00% | 0.00% |
| CURIO WEALTH, LLC | 05/12/2026 | 1 | $5 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| CLEARSTEAD ADVISORS, LLC | 05/06/2026 | 0 | $0 | -100.00% | 0.00% |
| LPL FINANCIAL LLC | 05/06/2026 | 0 | $0 | -100.00% | 0.00% |
| DRW SECURITIES, LLC | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cadrenal Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 21 institutional investors and hedge funds held shares of Cadrenal Therapeutics Inc. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 21,626
VANGUARD FIDUCIARY TRUST CO: 8,311
JPMORGAN CHASE & CO: 7,500
BlackRock, Inc.: 5,496
Tower Research Capital LLC (TRC): 393
ADVISOR GROUP HOLDINGS, INC.: 300
3.78% of Cadrenal Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 98.16 K shares in the last 24 months. This purchase volume represents approximately $785.26 K in transactions.